RESULTS FROM A PLATFORM-BASED CLINICAL TRIAL FOR PERSONS DIAGNOSED WITH MILD COGNITIVE IMPAIRMENT

Abstract The process of receiving a diagnosis mild cognitive impairment (MCI) is overwhelming. Individuals may experience adaptive or maladaptive responses to the diagnosis. Five specific areas response were previously identified, including 1) failure plan for future decline, 2) decreased compliance and interaction with medical care providers, 3) confidence reduced social engagement, 4) increased physical limitations mobility, 5) medication compliance. This pilot study reports on delivery platform-based trial persons diagnosed MCI survey data qualitative focus groups (n=38). consisted single-site platform examining intervention group. Using this approach allowed participants explore different biopsychosocial arms intervention. Second, design researchers determine effects interventions patient help-seeking adherence behavior in real-world care. Feasibility, opportunities, challenges will be discussed. Opportunities include group’s cohesion group-based intervention, which engagement group participation. Additionally, most susceptive components that novel (i.e., mindfulness) administered by professional pharmacist, therapist) as opposed self-facilitated activities. Challenges frequency visits, partner requirement, in-person These further compounded COVID-19 pandemic. Findings from offer considerations implementing support programming clinical research MCI. presentation also discussion pandemic-related protocol modifications study.